These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 28963303)
61. Randomised controlled trial and economic analysis of an internet-based weight management programme: POWeR+ (Positive Online Weight Reduction). Little P; Stuart B; Hobbs FR; Kelly J; Smith ER; Bradbury KJ; Hughes S; Smith PW; Moore MV; Lean ME; Margetts BM; Byrne CD; Griffin S; Davoudianfar M; Hooper J; Yao G; Zhu S; Raftery J; Yardley L Health Technol Assess; 2017 Jan; 21(4):1-62. PubMed ID: 28122658 [TBL] [Abstract][Full Text] [Related]
62. The syndrome of pseudotumour cerebri and idiopathic intracranial hypertension. Fraser C; Plant GT Curr Opin Neurol; 2011 Feb; 24(1):12-7. PubMed ID: 21150597 [TBL] [Abstract][Full Text] [Related]
63. Update on Idiopathic Intracranial Hypertension Management. Souza MNP; Costa BAL; Santos FRDR; Fortini I Arq Neuropsiquiatr; 2022 May; 80(5 Suppl 1):227-231. PubMed ID: 35976300 [TBL] [Abstract][Full Text] [Related]
64. Cerebellar tonsillar herniation after weight loss in a patient with idiopathic intracranial hypertension. Graber JJ; Racela R; Henry K Headache; 2010 Jan; 50(1):146-8. PubMed ID: 19817881 [TBL] [Abstract][Full Text] [Related]
65. Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. Skau M; Sander B; Milea D; Jensen R J Neurol; 2011 Feb; 258(2):277-83. PubMed ID: 20853113 [TBL] [Abstract][Full Text] [Related]
66. Idiopathic intracranial hypertension VISION (venous intervention versus shunting in IIH for optic nerve disc swelling) trial: patient perspective questionnaire. Chandran A; Pulhorn H; McMahon C Br J Neurosurg; 2019 Feb; 33(1):71-75. PubMed ID: 28934871 [TBL] [Abstract][Full Text] [Related]
67. Novel Approaches to the Treatment of Idiopathic Intracranial Hypertension. Subramanian PS Curr Neurol Neurosci Rep; 2024 Aug; 24(8):265-272. PubMed ID: 38864967 [TBL] [Abstract][Full Text] [Related]
68. Treatment of idiopathic intracranial hypertension with gastric bypass surgery. Levin AA; Hess D; Hohler AD Int J Neurosci; 2015 Jan; 125(1):78-80. PubMed ID: 24579748 [TBL] [Abstract][Full Text] [Related]
69. Impact of Ramadan fasting on vision and headache-related quality of life in women with idiopathic intracranial hypertension: A prospective observational study. Hussein M; Abdelghaffar M; Ali M; Yassein AM; Khalil DM; Magdy R Headache; 2024 Apr; 64(4):352-360. PubMed ID: 38525797 [TBL] [Abstract][Full Text] [Related]
70. Progress and recognition of idiopathic intracranial hypertension: A narrative review. Zhou C; Zhou Y; Liu L; Jiang H; Wei H; Zhou C; Ji X CNS Neurosci Ther; 2024 Aug; 30(8):e14895. PubMed ID: 39097911 [TBL] [Abstract][Full Text] [Related]
71. Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial. Bruce BB; Digre KB; McDermott MP; Schron EB; Wall M; Neurology; 2016 Nov; 87(18):1871-1877. PubMed ID: 27694262 [TBL] [Abstract][Full Text] [Related]
72. Idiopathic intracranial hypertension: relation between obesity and visual outcomes. Szewka AJ; Bruce BB; Newman NJ; Biousse V J Neuroophthalmol; 2013 Mar; 33(1):4-8. PubMed ID: 22217456 [TBL] [Abstract][Full Text] [Related]
73. Predictive role of presenting symptoms and clinical findings in idiopathic intracranial hypertension. Radojicic A; Vukovic-Cvetkovic V; Pekmezovic T; Trajkovic G; Zidverc-Trajkovic J; Jensen RH J Neurol Sci; 2019 Apr; 399():89-93. PubMed ID: 30782528 [TBL] [Abstract][Full Text] [Related]
74. Idiopathic intracranial hypertension is not benign: a long-term outcome study. Yri HM; Wegener M; Sander B; Jensen R J Neurol; 2012 May; 259(5):886-94. PubMed ID: 22008872 [TBL] [Abstract][Full Text] [Related]
75. A feasibility randomised controlled trial of a motivational interviewing-based intervention for weight loss maintenance in adults. Simpson SA; McNamara R; Shaw C; Kelson M; Moriarty Y; Randell E; Cohen D; Alam MF; Copeland L; Duncan D; Espinasse A; Gillespie D; Hill A; Owen-Jones E; Tapper K; Townson J; Williams S; Hood K Health Technol Assess; 2015 Jul; 19(50):v-vi, xix-xxv, 1-378. PubMed ID: 26168409 [TBL] [Abstract][Full Text] [Related]
76. Idiopathic intracranial hypertension in the British population with obesity. Ardissino M; Moussa O; Tang A; Muttoni E; Ziprin P; Purkayastha S Acta Neurochir (Wien); 2019 Feb; 161(2):239-246. PubMed ID: 30564882 [TBL] [Abstract][Full Text] [Related]
77. Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial. Libien J; Kupersmith MJ; Blaner W; McDermott MP; Gao S; Liu Y; Corbett J; Wall M; J Neurol Sci; 2017 Jan; 372():78-84. PubMed ID: 28017254 [TBL] [Abstract][Full Text] [Related]
78. Primary spontaneous cerebrospinal fluid rhinorrhea: a symptom of idiopathic intracranial hypertension? Yang Z; Wang B; Wang C; Liu P J Neurosurg; 2011 Jul; 115(1):165-70. PubMed ID: 21476806 [TBL] [Abstract][Full Text] [Related]
79. [Idiopathic intracranial hypertension]. Sergeev AV Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):93-97. PubMed ID: 27240187 [TBL] [Abstract][Full Text] [Related]
80. Should topiramate be initial therapy in the management of idiopathic intracranial hypertension?: A literature review. Goyal A; Zarroli K Medicine (Baltimore); 2023 Oct; 102(42):e35545. PubMed ID: 37861536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]